Becton, Dickinson Completes Its Acquisition Of CareFusion - Quick Facts

(RTTNews) - Becton, Dickinson and Co. (BDX) said it completed its acquisition of CareFusion Corp., following the previously announced Agreement and Plan of Merger, dated October 5, 2014.

CareFusion has become a wholly-owned subsidiary of BD and each outstanding share of common stock, par value $0.01 per share, of CareFusion was converted into the right to receive $49.00 in cash, without interest and 0.0777 of a share of common stock, par value $1.00 per share, of BD.

As a result of the completion of the acquisition, CareFusion shares will cease trading, and will be delisted from the New York Stock Exchange.

Excluding transaction-related expenses relating to the closing, BD expects the acquisition to have an immaterial impact on the company's results of operations in the second fiscal quarter, which ends on March 31.

In October 2014, BD agreed to buy medical devices maker CareFusion for $12.2 billion in a cash-and-stock deal.